How a 6% structural change mimics a hormone to curb hunger

Semaglutide (Ozempic, Wegovy, Rybelsus) - Mechanisms of Action and Pharmacology, Animation · 5:14 · Video: Alila Medical Media · Watch at the source

In short: Semaglutide is a pharmaceutical marvel that mimics a natural hormone to regulate metabolism. By slightly altering a peptide's structure, scientists created a medication that tricks the body into feeling full, slowing digestion, and balancing blood sugar. It is a masterclass in molecular engineering.

Semaglutide is a GLP-1 receptor agonist, meaning it mimics the action of glucagon-like peptide-1, a hormone released naturally in the body within minutes of eating. In a healthy system, GLP-1 stimulates insulin secretion and inhibits glucagon to manage blood glucose. However, natural GLP-1 is extremely short-lived because it is quickly degraded by the enzyme DPP-4. Semaglutide was engineered with a 94% structural homology to this natural hormone, with a specific 6% difference that protects it from DPP-4 degradation and delays its clearance by the kidneys.

The medication works through a multi-pronged approach. In the pancreas, it manages blood sugar in a glucose-dependent manner by increasing insulin and decreasing glucagon. In the gastrointestinal tract, it slows gastric emptying, which physically extends the feeling of satiety and delays the arrival of glucose into the bloodstream. Furthermore, it acts on the hypothalamus in the brain to directly reduce the sensation of hunger. These combined actions make it effective for both type 2 diabetes management and obesity treatment.

Beyond weight and glucose, research suggests semaglutide may influence broader metabolic health. Preclinical studies in rodents indicate it might modulate adipose tissue browning—a process that enhances metabolism—and may offer anti-inflammatory or antioxidant effects. While these specific mechanisms, including potential benefits for skeletal muscle degeneration and anti-aging, are not yet confirmed in humans, they provide a framework for future research into how the drug interacts with inflammation and oxidative stress.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/health-semaglutide-ozempic-wegovy-rybelsus-mechanisms-of-action-and.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…